Ferro (FOE) completes sale of pharmaceutical business to PLI Holdings for $16.9M in cash and up...

|About: Ferro Corporation (FOE)|By:, SA News Editor

Ferro (FOE) completes sale of pharmaceutical business to PLI Holdings for $16.9M in cash and up to $8M in incentive payments over two years. The company is selling non-core assets as it seeks to pacify skeptical shareholders who believe the company should have accepted what SA contributor Dr. Jacques Saint-Pierre called a "fair" buyout offer last month.